Company news

Bavarian Nordic A/S news in 2025

Bavarian Nordic A/S's news releases, calls and decks from 2025, newest first.

View company

Bavarian Nordic Establishes Long-term Incentive Program for Members of Executive Management and Selected Employees

December 18, 2025

Heidi Hunter Appointed New Vice Chair of the Board of Directors of Bavarian Nordic

December 17, 2025

Bavarian Nordic to Launch Share Buy-back Program of up to DKK 500 Million

December 2, 2025

Bavarian Nordic to Host a Shareholder Information Meeting on December 11, 2025 in Copenhagen

November 26, 2025

Bavarian Nordic Announces Interim Results for the First Nine Months of 2025

November 14, 2025

Bavarian Nordic Announces Changes to the Board of Directors

November 13, 2025

Bavarian Nordic Announces Major Shareholder Notification from Morgan Stanley

November 10, 2025

Consortium consisting of Nordic Capital and Permira announces preliminary result of the takeover offer to shareholders of Bavarian Nordic and that the Offer is withdrawn and will not be completed

November 6, 2025

Bavarian Nordic Provides Clarification on the HERA Framework Agreement and the Public Preparedness Business

November 1, 2025

Bavarian Nordic shareholders are reminded of expiry of the offer period regarding the takeover offer from consortium consisting of Nordic Capital and Permira

October 31, 2025

Bavarian Nordic Awarded New Procurement Framework Contract by the European Commission to Strengthen Preparedness Against Smallpox and Mpox

October 31, 2025

Bavarian Nordic Provides Further Support to Mpox Outbreak in Africa through Additional Donation of Vaccines

October 28, 2025

Consortium consisting of Nordic Capital and Permira lowers the minimum acceptance condition to 66 2/3% in respect of the takeover offer to the shareholders of Bavarian Nordic

October 21, 2025

The Board of Directors maintains its recommendation in supplementary statement in respect of the improved takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira

October 16, 2025

Consortium consisting of Nordic Capital and Permira increases offer price and extends offer period until 5 November 2025 in respect of the takeover offer to the shareholders of Bavarian Nordic

October 15, 2025

Consortium consisting of Nordic Capital and Permira receives final regulatory approval in respect of its takeover offer to the shareholders of Bavarian Nordic

October 9, 2025

Bavarian Nordic Reports Positive Topline Data for Mpox/Smallpox Vaccine in Pediatric Population

October 7, 2025

Consortium consisting of Nordic Capital and Permira extends offer period until 14 October 2025 and provides update on regulatory approvals in respect of the takeover offer to the shareholders of Bavarian Nordic

September 29, 2025

Societe Generale: shares & voting rights as of 31 August 2025

September 9, 2025

Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise

September 5, 2025

Publication of statement by the Board of Directors in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira

August 26, 2025

Publication of offer document in respect of the takeover offer to the shareholders of Bavarian Nordic from the consortium led by Nordic Capital and Permira and lowering of minimum acceptance condition to 75%

August 26, 2025

Bavarian Nordic Announces First Half 2025 Results

August 22, 2025

Bavarian Nordic Announces Closing of Sale of Priority Review Voucher and Upgrades its 2025 Financial Guidance

July 31, 2025

Consortium Led by Nordic Capital and Permira Will Make All-Cash Recommended Purchase Offer for Bavarian Nordic

July 28, 2025

Rumours of a Potential Takeover Offer for Bavarian Nordic A/S

July 24, 2025

Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine

July 22, 2025

Bavarian Nordic Enters New Smallpox/Mpox Vaccine Supply Contract with European Country

July 9, 2025

Bavarian Nordic Announces the Initiation of Clinical Trials of Mpox Vaccine in Infants and Pregnant Women

June 26, 2025

Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million

June 18, 2025

Bavarian Nordic Initiates Phase 3 Study of Chikungunya Vaccine in Children

June 12, 2025

Bavarian Nordic Announces Interim Results for the First Three Months of 2025

May 9, 2025

Bavarian Nordic Awarded Contract Options from the U.S. Government for Production and Supply of Freeze-dried Smallpox/Mpox Vaccines

May 6, 2025

Bavarian Nordic Receives Marketing Authorization for Chikungunya Vaccine for Persons Aged 12 and Older in the United Kingdom

May 2, 2025

Calls in 2025

Decks in 2025